“REDUCTION IN CONTROLLED ATTENUATION PARAMETER AND LIVER STIFFNESS WITH SAROGLITAZAR IN NAFLD: A PROSPECTIVE ANALYSIS” (2025) International Research Journal of Pharmacy, 16(2), pp. 38–49. doi:10.56802/y0zhqk37.